CAL
CGEM icon

Capital Advisors Ltd’s Cullinan Oncology CGEM Stock Holding History

Capital Advisors Ltd’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Hold
1,600
– – ﹤0.01% 608
2026
Q1 		$23K Buy
+1,600
New +$20.6K ﹤0.01% 629
2023
Q4 		– Sell
-37
Closed – – 1313
2023
Q3 		$0 Hold
37
– – ﹤0.01% 1302
2023
Q2 		$0 Hold
37
– – ﹤0.01% 1314
2023
Q1 		$0 Hold
37
– – ﹤0.01% 1236
2022
Q4 		$0 Hold
37
– – ﹤0.01% 1260
2022
Q3 		$0 Hold
37
– – ﹤0.01% 1267
2022
Q2 		$0 Buy
+37
New +$420 ﹤0.01% 1038

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Capital Advisors Ltd's CGEM Position: Q2 2026 in Review

Capital Advisors Ltd held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 1,600 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #608.

Capital Advisors Ltd first reported a position in CGEM in Q2 2022 and has held it in 8 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Capital Advisors Ltd held 1,600 shares of Cullinan Oncology worth $29K as of Q2 2026.
  • Capital Advisors Ltd left its Cullinan Oncology share count unchanged in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #608 holding.
  • Capital Advisors Ltd first reported a position in Cullinan Oncology in Q2 2022 and has held it in 8 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.